{"id":148027,"date":"2025-11-17T09:29:31","date_gmt":"2025-11-17T02:29:31","guid":{"rendered":"https:\/\/vnras.com\/drug\/?post_type=product&p=148027"},"modified":"2025-11-17T09:31:46","modified_gmt":"2025-11-17T02:31:46","slug":"celecoxib-200-hv","status":"publish","type":"product","link":"https:\/\/vnras.com\/drug\/celecoxib-200-hv\/","title":{"rendered":"Celecoxib 200-HV"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, <\/strong>d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng<\/strong><\/a> gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n s\u1ea3n ph\u1ea9m thu\u1ed1c Celecoxib 200-HV<\/a> \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi<\/strong> C\u00f4ng ty c\u1ed5 ph\u1ea7n US Pharma USA, c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 893110250900 (S\u0110K c\u0169: VD-20109-13).<\/strong><\/p>\n

\"Thu\u1ed1c
Thu\u1ed1c Celecoxib 200-HV \u0111i\u1ec1u tr\u1ecb vi\u00eam x\u01b0\u01a1ng kh\u1edbp \u1edf b\u1ec7nh nh\u00e2n tr\u01b0\u1edfng th\u00e0nh<\/figcaption><\/figure>\n

Celecoxib 200-HV l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n

Th\u00e0nh ph\u1ea7n<\/h3>\n

Thu\u1ed1c Celecoxib 200-HV<\/strong> c\u00f3 ch\u1ee9a th\u00e0nh ph\u1ea7n: Celecoxib 200mg<\/p>\n

D\u1ea1ng b\u00e0o ch\u1ebf: Vi\u00ean nang c\u1ee9ng<\/p>\n

Tr\u00ecnh b\u00e0y<\/h3>\n

S\u0110K: 893110250900 (S\u0110K c\u0169: VD-20109-13)<\/p>\n

Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 10 v\u1ec9 x 10 vi\u00ean<\/p>\n

Xu\u1ea5t x\u1ee9: Vi\u1ec7t Nam<\/p>\n

H\u1ea1n s\u1eed d\u1ee5ng: 36 th\u00e1ng<\/p>\n

T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Celecoxib 200-HV<\/h2>\n

C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n

Trong c\u01a1 th\u1ec3 t\u1ed3n t\u1ea1i COX 1 v\u00e0 COX 2, trong \u0111\u00f3 COX 1 \u0111\u00f3ng vai tr\u00f2 x\u00fac t\u00e1c s\u1ea3n xu\u1ea5t ch\u1ea5t b\u1ea3o v\u1ec7 ni\u00eam m\u1ea1c d\u1ea1 d\u00e0y, COX 2 \u0111\u01b0\u1ee3c x\u00e1c \u0111\u1ecbnh trong c\u00e1c m\u00f4 s\u01b0ng vi\u00eam. Celecoxib thu\u1ed9c nh\u00f3m thu\u1ed1c NSAID, \u1ee9c ch\u1ebf ch\u1ecdn l\u1ecdc COX 2, \u1ee9c ch\u1ebf qu\u00e1 tr\u00ecnh t\u1ed5ng h\u1ee3p prostaglandin, h\u1ea1n ch\u1ebf t\u00e1c d\u1ee5ng ph\u1ee5 tr\u00ean \u0111\u01b0\u1eddng ti\u00eau h\u00f3a, tuy nhi\u00ean kh\u00f4ng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn qu\u00e1 tr\u00ecnh \u0111\u00f4ng m\u00e1u.<\/p>\n

\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n

Celecoxib s\u1eed d\u1ee5ng \u0111\u01b0\u1eddng u\u1ed1ng m\u1ee9c \u0111\u1ed9 h\u1ea5p thu kh\u00f4ng b\u1ecb \u1ea3nh h\u01b0\u1edfng b\u1edfi s\u1ef1 c\u00f3 m\u1eb7t c\u1ee7a th\u1ee9c \u0103n, n\u1ed3ng \u0111\u1ed9 \u0111\u1ec9nh \u0111\u1ea1t \u0111\u01b0\u1ee3c sau kho\u1ea3ng 3 gi\u1edd khi d\u00f9ng 1 li\u1ec1u \u0111\u1ea7u ti\u00ean. T\u1ef7 l\u1ec7 Celecoxib g\u1eafn k\u1ebft v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng kho\u1ea3ng 97%; chuy\u1ec3n h\u00f3a \u1edf gan qua CYP450 2C9. Thu\u1ed1c th\u1ea3i tr\u1eeb ch\u1ee7 y\u1ebfu qua ph\u00e2n v\u1edbi n\u01b0\u1edbc ti\u1ec3u v\u1edbi t\u1ef7 l\u1ec7 l\u1ea7n l\u01b0\u1ee3t l\u00e0 57% v\u00e0 27%.<\/p>\n

Thu\u1ed1c Celecoxib 200-HV \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n

Thu\u1ed1c Celecoxib 200-HV<\/strong> \u0111i\u1ec1u tr\u1ecb vi\u00eam kh\u1edbp d\u1ea1ng th\u1ea5p, vi\u00eam x\u01b0\u01a1ng kh\u1edbp \u1edf b\u1ec7nh nh\u00e2n tr\u01b0\u1edfng th\u00e0nh, gi\u1ea3m \u0111au trong \u0111au b\u1ee5ng kinh, \u0111i\u1ec1u tr\u1ecb polyp tuy\u1ebfn trong gia \u0111\u00ecnh.<\/p>\n

Li\u1ec1u d\u00f9ng c\u1ee7a thu\u1ed1c Celecoxib 200-HV<\/h2>\n

Li\u1ec1u d\u00f9ng<\/h3>\n\n\n\n\n\n\n\n\n\n
Ch\u1ec9 \u0111\u1ecbnh<\/td>\nLi\u1ec1u d\u00f9ng<\/td>\n<\/tr>\n
Vi\u00eam x\u01b0\u01a1ng kh\u1edbp<\/td>\nLi\u1ec1u duy nh\u1ea5t 1 vi\u00ean\/ng\u00e0y<\/td>\n<\/tr>\n
Vi\u00eam kh\u1edbp d\u1ea1ng th\u1ea5p<\/td>\n1 vi\u00ean\/l\u1ea7n x 2 l\u1ea7n\/ng\u00e0y<\/td>\n<\/tr>\n
\u0110au b\u1ee5ng kinh<\/td>\nLi\u1ec1u duy nh\u1ea5t 2 vi\u00ean\/ng\u00e0y \u0111\u1ea7u ti\u00ean<\/p>\n

Sau \u0111\u00f3 1 vi\u00ean\/l\u1ea7n x 2 l\u1ea7n\/ng\u00e0y<\/td>\n<\/tr>\n

Polyp tuy\u1ebfn trong gia \u0111\u00ecnh<\/td>\n2 vi\u00ean\/l\u1ea7n x 2 l\u1ea7n\/ng\u00e0y<\/td>\n<\/tr>\n
Suy gan nh\u1eb9-v\u1eeba<\/td>\n\u00bd li\u1ec1u b\u00ecnh th\u01b0\u1eddng<\/td>\n<\/tr>\n
Suy gan, suy th\u1eadn n\u1eb7ng<\/td>\nKh\u00f4ng s\u1eed d\u1ee5ng Celecoxib 200-HV<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

C\u00e1ch d\u00f9ng<\/h3>\n

Thu\u1ed1c Celecoxib 200-HV d\u1ea1ng vi\u00ean nang c\u1ee9ng, s\u1eed d\u1ee5ng \u0111\u01b0\u1eddng u\u1ed1ng, d\u00f9ng trong\/sau b\u1eefa \u0103n.<\/p>\n

Kh\u00f4ng s\u1eed d\u1ee5ng thu\u1ed1c Celecoxib 200-HV trong tr\u01b0\u1eddng h\u1ee3p n\u00e0o?<\/h2>\n

Ch\u1ed1ng ch\u1ec9 \u0111\u1ecbnh d\u00f9ng Celecoxib 200-HV cho tr\u01b0\u1eddng h\u1ee3p sau:<\/p>\n